SCHEMBL12050622

SCHEMBL12050622

CN1C(=O)NC(=O)C12Cc1cc3nc(/C=C/c4ccccc4)[nH]c3cc1C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CALCRL Q16602 6/20 0.49
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TUBB4A P04350 9/20 0.44
▸ TUBB P07437 9/20 0.44
▸ TUBA3C P0DPH7 9/20 0.44
▸ TUBA1B P68363 9/20 0.44
▸ TUBA4A P68366 9/20 0.44
▸ TUBB4B P68371 9/20 0.44
▸ TUBB3 Q13509 9/20 0.44
▸ TUBB2A Q13885 9/20 0.44
▸ TUBB8 Q3ZCM7 9/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12050633 0.79 CALCRL (0.50) CALCRLNPC1RAB9AKDM4EALDH1A1
SCHEMBL12050348 0.78 CALCRL (0.49) CALCRLCALCA
SCHEMBL12050643 0.76 CALCRL (0.47) CALCRLCALCA
SCHEMBL12050415 0.74 CALCRL (0.61) CALCRLKDM4EALDH1A1HPGDCALCA
SCHEMBL12990901 0.74 CALCA (0.47) CALCRLNPC1RAB9AKDM4EMEN1
SCHEMBL12050642 0.73 CALCRL (0.45) CALCRLKDM4EMEN1ALDH1A1HPGD
SCHEMBL12060842 0.73 CALCRL (0.55) CALCRLKDM4EKMT2ACALCA
SCHEMBL4623517 0.72 MEN1 (0.72) NPC1RAB9AKDM4EMEN1ALDH1A1
SCHEMBL12050619 0.72 CALCRL (0.54) CALCRLALDH1A1CALCA
SCHEMBL12050623 0.72 CALCRL (0.47) CALCRLCALCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071770-B2 Spirohydantoin aryl CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-12-06 — — US disclosed
US-8071770-B2 Spirohydantoin aryl CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-12-06 — — US disclosed
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2009-09-24 — — US disclosed
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2009-09-24 — — US disclosed
WO-2007061676-A2 SPIROHYDANTOIN ARYL CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2007-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists BDKRB1, BDKRB2, CALCRL CALCRL 3/4885NPC1 706/4885RAB9A 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback